NuThrax (AV7909) / Emergent Biosolutions  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

   Remove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
NuThrax (AV7909) / Emergent Biosolutions
ABESt, NCT05997264: Anthrax AV7909 Boost Evaluation Study

Active, not recruiting
2
220
NA
AV7909 Full Dose (0.5 mL), AV7909 Half Dose (0.25 mL)
Biomedical Advanced Research and Development Authority, Rho Federal Systems Division, Inc., ICON plc
Anthrax
08/25
08/26

Download Options